Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.3921
-0.0287 (-6.82%)
At close: Apr 1, 2025, 4:00 PM
0.3938
+0.0017 (0.43%)
After-hours: Apr 1, 2025, 6:55 PM EDT

Cognition Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-33.97-25.79-21.4-11.72-7.84
Upgrade
Depreciation & Amortization
0.270.250.240.090.1
Upgrade
Other Amortization
---0.380.84
Upgrade
Stock-Based Compensation
3.754.353.575.180.48
Upgrade
Other Operating Activities
0.20.32--0.42-0.07
Upgrade
Change in Accounts Receivable
--0.470.120.9
Upgrade
Change in Accounts Payable
1.852.44-0.752.17-0.36
Upgrade
Change in Unearned Revenue
-0.64-1.692.640.5-
Upgrade
Change in Other Net Operating Assets
0.074.09-3.30.062.53
Upgrade
Operating Cash Flow
-28.47-16.02-18.53-3.63-3.43
Upgrade
Capital Expenditures
-0-0.15-0.17-0.03-0.01
Upgrade
Investing Cash Flow
-0-0.15-0.17-0.03-0.01
Upgrade
Long-Term Debt Issued
----5.82
Upgrade
Short-Term Debt Repaid
-0.74-0.81-1.4-0.27-
Upgrade
Long-Term Debt Repaid
-----0
Upgrade
Total Debt Repaid
-0.74-0.81-1.4-0.27-0
Upgrade
Net Debt Issued (Repaid)
-0.74-0.81-1.4-0.275.81
Upgrade
Issuance of Common Stock
25.765.336.9461.250.05
Upgrade
Repurchase of Common Stock
-0.13----
Upgrade
Other Financing Activities
-1.33---7.78-0.09
Upgrade
Financing Cash Flow
23.574.525.5553.25.77
Upgrade
Foreign Exchange Rate Adjustments
-0-0-0.01-0.02
Upgrade
Net Cash Flow
-4.91-11.64-13.1649.532.3
Upgrade
Free Cash Flow
-28.48-16.17-18.7-3.66-3.44
Upgrade
Free Cash Flow Per Share
-0.72-0.54-0.79-0.70-6.78
Upgrade
Levered Free Cash Flow
-28.76-23.04-26.27-10.74-8.45
Upgrade
Unlevered Free Cash Flow
-28.75-23.02-26.25-10.56-8.19
Upgrade
Change in Net Working Capital
-0.97-4.222.67-2.06-2.12
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q